Clinical trial
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
NCT00004754 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 1993
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.